Marcel Trefny (@MarcelTrefny) profile picture

Scientist working on Cellular Cancer Immunotherapies @LMU_Uniklinikum. Previously working with @AlfredZippelius @DepBiomedicine

Joined October 2011
Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)Photo by Marcel Trefny (@MarcelTrefny)
Huge congratulations to Prof. Sebastian Kobold for receiving an @ERC_Research consolidator grant for his project: CATACLIS - Cancer tailored next generation cellular therapies💐@LMU_Muenchen #ERC
1
2
20
1,243
Marcel Trefny retweeted
#OnlineFirst: Read the In the Spotlight commentary— Unraveling #Tcell exhaustion: genetic screening meets in vitro modeling, by @AlfredZippelius, @MarcelTrefny, @priska_adm, and Schmid describing a recent @SciImmunology paper from the @EJohnWherry group. bit.ly/49iKo2s
5
7
1,480
Great collaboration with Hutter lab. Philip Schmassmann identifies Sig9 as new target in GBM. #glycotime Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma | Science Translational Medicine science.org/doi/10.1126/scit…
2
7
24
1,850
The Bassermann lab @TumTransla has several open #positions in #Munich #postdoc tinyurl.com/ywvwyc22 #PhD tinyurl.com/mpxpukt2 and a technical assistant tinyurl.com/2dmm22d8 Are you a science enthusiast, interested in cancer biology and protein turnover grab a seat🍻
1
5
5
1,534
We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇 cell.com/immunity/fulltext/S… A short 🧵:
16
54
4
220
45,340
Delighted to share our latest research following T cell receptor (TCR) by 3D TEM and showing ectocytosis makes TCR signalling self limiting at the immune synapse. Many thanks to everyone involved. @griffiths_lab science.org/doi/10.1126/scie…
1
4
31
1,757
#Koboldlab news: Big congrats to Florian Märkl and @BenmebarekMr and everyone involved @SophiaStock_ @cadilhabl @philippjie @MarrCarsten @BergweltMichael 🍸🍸
New #JITC article: Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma https://teapawt.net/t.co/fI4gQaxpgx @SophiaStock_
3
12
1,183
New #JITC article: Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity https://teapawt.net/t.co/L6YknZXZsv @NKirchhammer @KarenODixon @AlfredZippelius @MikaelPittet
6
1
14
3,918
👇We have a #Postdoc position funded by @EMBO @EMBO_YIP to study tissue-specific immune regulation of metastasis. Come join us in #Lisbon @Neuro_CF @ChampalimaudF 👉Apply: correialab.com/join-the-team…
29
5
84
16,481
Very excited to share our work on #resistance to PI3Kα inhibition in #BreastCancer published online today in @CellRepMed 🤩 #OpenAccess 📰 cell.com/cell-reports-medici… Summary 🧵👇 1/10
6
12
2
32
4,736
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia go.nature.com/3Tg3gHY
1
47
6
184
55,169
Thrilled to share my Perspective on how #TissueImmunity selectively restrains the growth of metastases - an exciting avenue for developing #Immunotherapies for long-lasting control of #Metastasis Thanks Lucy Bird and @NatRevImmunol for the opportunity! 👉rdcu.be/c4539
20
96
9
447
78,684
Targeting SNX9 to prevent CD8 T cell exhaustion and enhance anti-tumor immunity. nature.com/articles/s41467-0… @MarcelTrefny @AlfredZippelius @DepBiomedicine @NKirchhammer @priska_adm #CancerResearch @natrescancer
4
2
15
4,871
Will exhausted immune cells soon no longer be an issue? A research group funded by the SNSF has discovered that inactivation of a gene improves the endurance of #immunecells that tackle #cancer. sohub.io/pq18
3
5
1,589
A new @ScienceTM Viewpoint reviews recent developments in #immunotherapy for solid tumors and highlights progress in translational research and clinical practice. scim.ag/Ht
2
70
3
224
Die Resultate sind da: Ja zu Klimagerechtigkeit und Nettonull bis 2037! ✊🌍 Wir freuen uns, dass die Basler*innen bis auf das Zieljahr alle unsere Forderungen in die Kantonsverfassung aufgenommen haben.
2
23
1
78
Our viewpoint on combination immunotherapies to overcome resistance. Together with @AlfredZippelius @NKirchhammer @MarcelTrefny and @priska_adm. Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment science.org/doi/10.1126/scit…